MSD makes $1.4bn bid on biopharma company

22-11-2022

Staff Writer

MSD makes $1.4bn bid on biopharma company

Atmosphere1 / Shutterstock.com

Move could garner ‘milestone’ treatment for one of MSD’s portfolios | Activity comes after a Spanish watchdog fined the pharma firm $39 million.


Merck Sharp and Dohme, MSD, Merck & Co, Imago BioSciences, mergers and acquisitions, M&A, cancer, haematology

LSIPR